Film star Angelina Jolie will have her ovaries removed to help lower her odds for ovarian cancer, People magazine reported Wednesday. The news comes just a day after Jolie, 37, revealed in an article published on the editorial page of The New York Times that she had undergone a double mastectomy. Jolie wrote that she made the decision after learning she carried a gene, called BRCA1, that is linked to a significantly higher risk for both breast and ovarian cancers.
RELATED CONDITIONS
Advertisement
WEEKLY NEWSLETTER
Free Health for Women Email Newsletter
Stay fit, feel younger, and get insider health news—from beauty to breast cancer—just for women.
Hysterectomy May Not Raise Heart Risks After All: Study
May 14, 2013
By Steven ReinbergHealthDay Reporter
TUESDAY, May 14 (HealthDay News) — Women who have a hysterectomy are not in danger of increasing their risk of cardiovascular disease later in life, a new study says.
Although earlier research had found higher chances of cardiovascular disease in the years following a hysterectomy, different criteria were used in this latest study, [...]
Human Gene Patent Case Goes to Supreme Court
April 15, 2013
By Margaret SteeleHealthDay Reporter
MONDAY, April 15 (HealthDay News) — The question of whether human genes can be patented is at the center of a case to be heard Monday by the U.S. Supreme Court.
The court’s decision could have a profound effect on medical research in the country, efforts to fight diseases such as breast and [...]
Experimental Vaccine Shows Promise for Ovarian Cancer
April 6, 2013
By Randy DotingaHealthDay Reporter
SATURDAY, April 6 (HealthDay News) — A novel but preliminary new treatment for ovarian cancer has apparently produced complete remission for one patient with an advanced form of the disease, researchers are reporting.
The promising results of a phase 1 clinical trial for the immunotherapy approach also showed that seven other women had [...]
More Genetic Insights Into 3 Types of Cancer
March 27, 2013
By Barbara Bronson GrayHealthDay Reporter
WEDNESDAY, March 27 (HealthDay News) — Critical clues to understanding who is at the greatest risk for particular types of cancer may be found in “spelling mistakes” contained in a person’s DNA.
In a step toward personalized medicine and the ability to better understand individual risk factors for three common hormone-related cancers, [...]
Night Shift Linked to Risk of Ovarian Cancer
March 15, 2013
Working at night might do more than throw your schedule out of whack, researchers warn. Women who cover the night shift may be at increased risk for ovarian cancer, according to a new study. The investigators also found that the risk of ovarian cancer may be lower for night types (“owls”) than for morning types (“larks”).
Pap Test Could Spot Some Ovarian Cancers, Study Finds
January 10, 2013
With no routine screening test currently available for uterine or ovarian cancer — the latter of which is extremely lethal — scientists have found promise in a new method that can detect both types using cervical fluid obtained during routine Pap tests.
Common Diabetes Drug Shows Promise as Ovarian Cancer Treatment
December 3, 2012
By Mary Brophy MarcusHealthDay Reporter
MONDAY, Dec. 3 (HealthDay News) — Ovarian cancer may join a growing list of malignancies that seem to be slowed by a commonly prescribed diabetes drug.
Ovarian cancer patients who were taking metformin at the time of their diagnosis survived longer than patients who weren’t on the drug, a new study by [...]
Quick Survey May Pick Up Ovarian Cancer Warnings: Study
September 28, 2012
A simple three-question survey might identify women who have symptoms that may indicate ovarian cancer, according to a new study. The two-minute paper-and-pencil questionnaire can be given in a doctor’s office and checks for six warning signs that may improve early detection of ovarian cancer, according to researchers at the Fred Hutchinson Cancer Research Center in Seattle.
U.S. Panel Rejects Ovarian Cancer Screens for Low-Risk Women
September 11, 2012
A leading U.S. government panel has recommended against ovarian cancer screening for women who are not at high risk for the disease. Tests that are currently used to spot ovarian cancer may cause more harm than benefit for those patients, according to final guidelines issued Monday by the U.S. Preventive Services Task Force. Women who have the genetic mutations (BRCA1/BRCA2) or family histories that raise their chances of developing ovarian cancer should be referred for genetic testing and counseling, the recommendations add.
Previous Ovarian Cancer Stories
U.S. Panel Rejects Ovarian Cancer Screening
04/10/2012 - Ovarian CancerBlack Women, Uninsured Get Worse Ovarian Cancer Care: Study
03/27/2012 - Money, Ovarian CancerEndometriosis Could Raise Risk of 3 Ovarian Cancers
02/22/2012 - Ovarian CancerGene Mutations May Boost Ovarian Cancer Survival: Study
01/24/2012 - Ovarian CancerAvastin May Help Some With Ovarian Cancer: Studies
12/28/2011 - Ovarian CancerFamily Tree May Affect Diagnosis Age in Some Breast Cancers
12/08/2011 - Breast Cancer, Ovarian CancerVaccine to Treat Breast, Ovarian Cancers Shows Promise
